Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Satoshi Yuasa"'
Publikováno v:
2021 International Symposium on Intelligent Signal Processing and Communication Systems (ISPACS).
Autor:
Dae Wook Kim, Katsuya Teshima, Takumi Nakanishi, Satoshi Yuasa, Nobuyuki Zettsu, Tomohito Sudare, Kunio Yubuta
Publikováno v:
Crystal Growth & Design. 18:4111-4116
Well-defined, platelet-shaped LiNbO3 single crystals were prepared by a flux-mediated topochemical reaction from platelet K4Nb6O17 crystals with a mixture of LiNO3 solute and alkali metal nitrate (LiNO3, NaNO3, and KNO3) fluxes at 600 °C. Crystallog
Autor:
Masaru Ubasawa, Yoshiyuki Fujimura, Naoko Ueda, Hideaki Takashima, Satoshi Yuasa, Kouichi Sekiya, Naohiro Kamiya
Publikováno v:
Journal of Medicinal Chemistry. 45:3138-3142
Novel 2-amino-6-arylthio-9-[2-(phosphonomethoxy)ethyl]purine bis(2,2,2-trifluoroethyl) esters were synthesized and evaluated for antihepatitis B virus (HBV) activity in vitro using HB611, HuH-6 cell line, stably transfected with the HBV genome. Among
Publikováno v:
Antiviral Chemistry and Chemotherapy. 12:161-167
Emivirine (EMV) is a non-nucleoside reverse transcriptase inhibitor currently undergoing Phase III clinical trials in HIV-1-infected patients. In this study, the anti-HIV-1 activity of EMV in combination with two nucleoside reverse transcriptase inhi
Autor:
Satoshi Yuasa, Kazunori Kajino, Okio Hino, Ken Ichi Yamamura, Naohiro Kamiya, Junko Sakurai, Tomoko Takahara
Publikováno v:
Biochemical and Biophysical Research Communications. 241:43-48
For evaluation of anti-hepatitis B virus (HBV) drugs, we have employed the HBV transgenic mouse in which virion-like particles can be assayed in the serum. Bispivaloyloxymethyl-9-(2-phosphonylmethoxyethyl)-adenine [bis (POM) PMEA] 100 mg/kg/day, 2',3
Publikováno v:
Antiviral Research. 31:69-77
We have investigated viral breakthrough during a long-term culture of HIV-1-infected cells with the non-nucleoside reverse transcriptase inhibitors (NNRTIs) 6-benzyl-1-ethoxymethyl-5-isopropyluracil (MKC-442), nevirapine and loviride (alpha-APA). Whe
Autor:
Masanori Baba, Richard T. Walker, Tadashi Miyasaka, Masaru Ubasawa, Erik De Clercq, Satoshi Yuasa, Hlromichi Tanaka
Publikováno v:
Nucleosides, Nucleotides and Nucleic Acids. 14:575-583
The 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives have been found to be potent and specific inhibitors of human immunodeficiency virus type 1 (HIV-1) replication in vitro. Among the compounds, MKC-442 (6-benzyl-1-ethoxymethyl-5
Autor:
Keiko Sudo, Maki Sato, Takehisa Ishii, Masayuki Suzuki, Kohei Umezu, Tadashi Hishida, Satoshi Yuasa, Hiroshi Nakai, Takuro Niwa
Publikováno v:
The Journal of Biochemistry. 117:1105-1112
The effects of recombinant human hepatocyte growth factor (HGF) on liver growth and function of normal and partially hepatectomized rats have been examined. HGF was continuously administered into the jugular vein because it was rapidly eliminated fro
Autor:
T. Miyasaka, R. T. Walker, Shiro Shigeta, H Takashima, Masanori Baba, Kouichi Sekiya, E. De Clercq, H Tanaka, Satoshi Yuasa, M Ubasawa
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:688-692
MKC-442 (6-benzyl-1-ethoxymethyl-5-isopropyluracil or I-EBU) has recently been identified as a highly potent and specific inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. Since the compound has favorable pharmacokinetic
Publikováno v:
ChemInform. 26